D. E. Shaw & Co. Inc. Has $1.96 Million Stock Position in AdaptHealth Corp. (NASDAQ:AHCO)

D. E. Shaw & Co. Inc. reduced its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 59.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 205,590 shares of the company's stock after selling 301,092 shares during the quarter. D. E. Shaw & Co. Inc. owned 0.15% of AdaptHealth worth $1,957,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Assetmark Inc. bought a new stake in shares of AdaptHealth in the 4th quarter worth about $28,000. Blue Trust Inc. grew its stake in AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after buying an additional 1,115 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in AdaptHealth by 15.4% during the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after buying an additional 1,690 shares during the last quarter. Guggenheim Capital LLC increased its holdings in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after buying an additional 1,525 shares in the last quarter. Finally, KLP Kapitalforvaltning AS bought a new stake in AdaptHealth during the 4th quarter worth approximately $169,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Trading Up 6.0%

NASDAQ AHCO traded up $0.53 during trading on Tuesday, reaching $9.31. 1,232,107 shares of the stock traded hands, compared to its average volume of 1,285,537. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of -5.64, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The stock's 50-day moving average price is $9.04 and its 200 day moving average price is $9.63.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Royal Bank of Canada reduced their price objective on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. Truist Financial reduced their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. UBS Group lowered their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Robert W. Baird upped their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Finally, Canaccord Genuity Group increased their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.